209 related articles for article (PubMed ID: 3929660)
1. Determination of in vitro susceptibility of mycobacteria to ansamycin.
Heifets LB; Iseman MD
Am Rev Respir Dis; 1985 Sep; 132(3):710-1. PubMed ID: 3929660
[TBL] [Abstract][Full Text] [Related]
2. Two groups of Mycobacterium avium complex strains determined according to the susceptibility to rifampicin and ansamycin.
Tsukamura M
Microbiol Immunol; 1987; 31(7):615-23. PubMed ID: 3125413
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin.
Woodley CL; Kilburn JO
Am Rev Respir Dis; 1982 Sep; 126(3):586-7. PubMed ID: 6289711
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of in vitro antimycobacterial activities of ansamycin and rifampicin].
Tsukamura M; Mizuno S; Toyama H; Ichiyama S
Kekkaku; 1986 Oct; 61(10):497-503. PubMed ID: 3100853
[No Abstract] [Full Text] [Related]
5. Determination of ansamycin MICs for Mycobacterium avium complex in liquid medium by radiometric and conventional methods.
Heifets LB; Iseman MD; Lindholm-Levy PJ; Kanes W
Antimicrob Agents Chemother; 1985 Oct; 28(4):570-5. PubMed ID: 4073881
[TBL] [Abstract][Full Text] [Related]
6. Rifabutine: minimal inhibitory and bactericidal concentrations for Mycobacterium tuberculosis.
Heifets LB; Lindholm-Levy PJ; Iseman MD
Am Rev Respir Dis; 1988 Mar; 137(3):719-21. PubMed ID: 2830815
[TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro activities of MDL 473, rifampin, and ansamycin against Mycobacterium intracellulare.
Cynamon MH
Antimicrob Agents Chemother; 1985 Sep; 28(3):440-1. PubMed ID: 4073865
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of Mycobacterium avium to a new macrolide (RU-28965).
Casal M; Rodriguez F; Villalba R
Chemotherapy; 1987; 33(4):255-8. PubMed ID: 3608625
[TBL] [Abstract][Full Text] [Related]
9. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
Akselband Y; Cabral C; Shapiro DS; McGrath P
J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth.
Wallace RJ; Nash DR; Steele LC; Steingrube V
J Clin Microbiol; 1986 Dec; 24(6):976-81. PubMed ID: 3097069
[TBL] [Abstract][Full Text] [Related]
11. [Study of the minimal inhibitory concentration of rifabutine (Ansamycin LM 427) for Mycobacterium tuberculosis, Mycobacterium xenopi and Mycobacterium avium-intracellulare].
Truffot-Pernot C; Giroir AM; Maury L; Grosset J
Rev Mal Respir; 1988; 5(4):401-6. PubMed ID: 2845531
[TBL] [Abstract][Full Text] [Related]
12. Bactericidal activity in vitro of various rifamycins against Mycobacterium avium and Mycobacterium tuberculosis.
Heifets LB; Lindholm-Levy PJ; Flory MA
Am Rev Respir Dis; 1990 Mar; 141(3):626-30. PubMed ID: 2155555
[TBL] [Abstract][Full Text] [Related]
13. [New active drugs against the tuberculosis bacillus and other mycobacteria].
de Kantor IN
Medicina (B Aires); 1986; 46(1):107-12. PubMed ID: 3100907
[No Abstract] [Full Text] [Related]
14. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis.
Foroumadi A; Soltani F; Moshafi MH
Boll Chim Farm; 2002; 141(5):394-6. PubMed ID: 12481384
[TBL] [Abstract][Full Text] [Related]
15. Antituberculosis agents. IX. In vitro antimycobacterial activity of N-(2-phenyl-2-oxoethyl) and N-[2-(4-fluorophenyl)-2-oxoethyl]ciprofloxacin derivatives against some drug-resistant strains of Mycobacterium tuberculosis and Mycobacterium avium isolates.
Foroumadi A; Soltani F
Boll Chim Farm; 2003; 142(6):248-50. PubMed ID: 14606264
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium, and rifampin against M. tuberculosis in cultured human macrophages.
Crowle AJ; Elkins N; May MH
Am Rev Respir Dis; 1988 May; 137(5):1141-6. PubMed ID: 3143278
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium avium against some quinolones.
Casal M; Rodriguez F; Villalba R; Benavente MC; Gonzalez AI
Chemioterapia; 1987 Dec; 6(6):431-3. PubMed ID: 3481302
[TBL] [Abstract][Full Text] [Related]
18. Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria.
Young LS; Berlin OG; Inderlied CB
Am J Med; 1987 Apr; 82(4A):23-6. PubMed ID: 3107379
[TBL] [Abstract][Full Text] [Related]
19. [In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains].
Thomas L; Naumann P; Crea A
Immun Infekt; 1986 Nov; 14(6):203-7. PubMed ID: 3100424
[TBL] [Abstract][Full Text] [Related]
20. In vitro activities of 2,2'-bipyridyl analogues against Mycobacterium avium and M. tuberculosis.
Dhople AM; Dhople AA; Ibanez MA
Tuber Lung Dis; 1995 Apr; 76(2):136-40. PubMed ID: 7780096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]